David Hollenback, PhD, is a seasoned toxicologist and pharmacologist currently serving as the Director of Toxicology at Rubedo Life Sciences. Previously, they were a Senior Research Scientist II at Gilead Sciences, where they supervised teams and led research on various therapeutic areas, contributing significantly to drug development processes. David’s expertise spans small molecules, peptides, and immunotherapeutics, with a focus on non-clinical pharmacology and translational clinical science models. They earned a Bachelor of Science from the University of Wisconsin-Madison and are pursuing a PhD in Biochemistry and Lipid Biology at the University of Washington.
This person is not in any teams
This person is not in any offices